Try our Advanced Search for more refined results

Analysis

3 Takeaways As China Rolls Out Its Version Of ANDA Disputes

By Ryan Davis (May 12, 2022, 8:35 PM EDT) -- A year after China launched a system for generic-drug patent disputes modeled on the U.S. Hatch-Waxman Act, the first decisions have come down. Here are the key things to know about the outcomes, including the rapid pace and early wins for generics makers against Roche and Purdue....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!